New

Substipharm

The AI engine Fit Assessment

Beta

Substipharm operates as a pharmaceutical group involved in research, development, regulatory affairs, manufacturing, and distribution of pharmaceuticals, generics, OTCs, and biologics/vaccines, with an international footprint and an active development pipeline.

Blurb

Substipharm is a pharmaceutical company that develops and supplies specialty medicines and therapeutic solutions.

HQ Location

Paris (France)

Founded

1995

Employees

51 - 200

Total funding raised

Not available

Funding Status

Not available

Substipharm is a privately held pharmaceutical Group.



We develop, supply and commercialize pharmaceuticals in more than 90 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 90 different molecules. Our development pipeline includes as well more than 50 ongoing projects.



We have a successful portfolio of pharmaceutical products and vaccines including:

Mature brands

Generics

Over the counter (OTC) pharmaceuticals

Difficult to develop medicines

Value added presentations

Biological products including vaccines: